Post by ELPRO Global

How can pharmaceutical companies accelerate product release while reducing GxP compliance risk and waste across the supply chain? In a recent interview, ELPRO’s Chief Sales Officer Christoph Bamert shares how a data-driven approach is transforming pharmaceutical logistics. By combining temperature and stability data from both stationary and in-transit monitoring into a single, product-level view, companies gain end-to-end visibility. Instead of relying on broad alarm limits, tracking individual stability budgets per product enables faster release decisions, reducing unnecessary quarantine and minimizing loss. Christoph also highlights the value of ambient temperature monitoring on passive packaging exteriors to identify lane risks, detect delays, and confirm controlled conditions during transit. As the industry evolves, data-driven decision-making will be key to improving efficiency, quality, and patient safety. Watch the full interview: Pharmaceutical Commerce: https://lnkd.in/edABnRRi Pharmaceutical Executive: https://lnkd.in/eY8CNpi5